Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 11
Submit an article Journal homepage
258
Views
3
CrossRef citations to date
0
Altmetric
Letter

Combination of albumin-bound paclitaxel and pegylated liposomal doxorubicin is effective in treatment of heavily treated relapsed/refractory diffuse large B-cell lymphoma: a case report

Liang WangDepartment of Hematological Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China
&
Zhong-Jun XiaDepartment of Hematological Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of ChinaCorrespondence[email protected]
Pages 2553-2555 | Received 24 Oct 2012, Accepted 08 Feb 2013, Published online: 27 Mar 2013

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Liang Wang, Xiao-qin Chen & Zhong-jun Xia. (2020) New tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma. Leukemia & Lymphoma 61:10, pages 2502-2506.
Read now
Sagun Goyal, Eunhye Oak, Jingqin Luo, Amanda F. Cashen, Kenneth Carson, Todd Fehniger, John DiPersio, Nancy L. Bartlett & Nina D. Wagner-Johnston. (2018) Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study. Leukemia & Lymphoma 59:2, pages 357-362.
Read now

Articles from other publishers (1)

Noah Trac & Eun Ji Chung. (2021) Overcoming physiological barriers by nanoparticles for intravenous drug delivery to the lymph nodes. Experimental Biology and Medicine 246:22, pages 2358-2371.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.